Prudential Financial’s Aquestive Therapeutics AQST Stock Holding History

Prudential Financial’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$73.5K	Buy	+17,705	New	+$71.9K	﹤0.01%	2267
2024 Q4	–	Sell	-14,475	Closed	-$72.1K	–	2294
2024 Q3	$72.1K	Buy	+14,475	New	+$56.3K	﹤0.01%	2610
2024 Q2	–	Sell	-20,200	Closed	-$86.1K	–	2693
2024 Q1	$86.1K	Sell	20,200 -4,800	-19%	-$16K	﹤0.01%	2539
2023 Q4	$50.5K	Hold	25,000	–	–	﹤0.01%	2549
2023 Q3	$38.3K	Buy	25,000 +2,600	+12%	+$4.47K	﹤0.01%	2527
2023 Q2	$37K	Buy	+22,400	New	+$40.5K	﹤0.01%	2563

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Prudential Financial's AQST Position: Q1 2026 in Review

Prudential Financial opened a new position in Aquestive Therapeutics (AQST) in Q1 2026: 17,705 shares worth $73.5K. The stake represents ﹤0.01% of the portfolio and ranks #2267 among its holdings. This is a return to the name: Prudential Financial previously reported a position in AQST as recently as Q3 2024.

Prudential Financial first reported a position in AQST in Q2 2023 and has held it in 6 quarters since. The position peaked at $86.1K in Q1 2024. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

Prudential Financial held 17,705 shares of Aquestive Therapeutics worth $73.5K as of Q1 2026.
Aquestive Therapeutics was a new Prudential Financial position in Q1 2026.
Aquestive Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2267 holding.
Prudential Financial first reported a position in Aquestive Therapeutics in Q2 2023 and has held it in 6 quarters since.
Prudential Financial's Aquestive Therapeutics position peaked at $86.1K in Q1 2024.
179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.